(-)-epigallocatechin 3-gallate decreases expression ISO RGD:731018 6480464 epigallocatechin gallate results in decreased expression of KDR protein, epigallocatechin gallate results in decreased expression of KDR protein modified form CTD PMID:17992120 , PMID:20346928 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of KDR mRNA CTD PMID:32512034 1,1-dichloroethene decreases expression ISO RGD:10836 6480464 vinylidene chloride results in decreased expression of KDR mRNA CTD PMID:26682919 1,2,4-trimethylbenzene increases expression EXP 6480464 pseudocumene results in increased expression of KDR protein CTD PMID:17337753 1,2-dimethylhydrazine multiple interactions ISO RGD:10836 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KDR mRNA CTD PMID:22206623 1,4-benzoquinone multiple interactions ISO RGD:731018 6480464 quinone analog binds to and results in decreased activity of KDR protein CTD PMID:16302797 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of KDR mRNA CTD PMID:17557909 17beta-estradiol multiple interactions ISO RGD:10836 6480464 2 more ... CTD PMID:17289903 17beta-estradiol increases expression ISO RGD:731018 6480464 Estradiol results in increased expression of KDR mRNA, Estradiol results in increased expression of KDR protein CTD PMID:25982407 , PMID:29890199 17beta-estradiol increases expression ISO RGD:10836 6480464 Estradiol results in increased expression of KDR protein CTD PMID:17289903 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of KDR protein CTD PMID:9214597 17beta-estradiol multiple interactions ISO RGD:731018 6480464 [Estradiol results in increased secretion of VEGFA protein] which results in increased expression of KDR protein, afimoxifene inhibits the reaction [Estradiol results in increased expression of KDR protein] CTD PMID:17289903 , PMID:29890199 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:10836 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:10836 6480464 2 more ... CTD PMID:30294300 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:10836 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:731018 6480464 Tetrachlorodibenzodioxin results in decreased expression of KDR mRNA CTD PMID:20106945 , PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of KDR mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of KDR mRNA CTD PMID:24475139 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10836 6480464 Tetrachlorodibenzodioxin affects the expression of KDR mRNA CTD PMID:16962184 , PMID:26377647 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of KDR mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of KDR mRNA CTD PMID:21346803 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine affects expression EXP 6480464 Puromycin Aminonucleoside affects the expression of KDR mRNA CTD PMID:11744811 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression EXP 6480464 Puromycin Aminonucleoside results in increased expression of KDR mRNA, Puromycin Aminonucleoside results in increased expression of KDR protein CTD PMID:14752241 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine decreases expression EXP 6480464 Puromycin Aminonucleoside results in decreased expression of KDR mRNA CTD PMID:17667850 3,3'-diindolylmethane decreases expression ISO RGD:731018 6480464 3, 3'-diindolylmethane analog results in decreased expression of KDR protein CTD PMID:25794856 3,5,6-trichloro-2-pyridinol increases expression ISO RGD:10836 6480464 3 more ... CTD PMID:23220036 , PMID:25137620 3,5,6-trichloropyridine-2-one increases expression ISO RGD:10836 6480464 3 more ... CTD PMID:23220036 , PMID:25137620 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO RGD:731018 6480464 bisindolylmaleimide I inhibits the reaction [AGT protein results in increased expression of KDR mRNA] CTD PMID:15005273 3-methylcholanthrene multiple interactions ISO RGD:10836 6480464 [Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of KDR mRNA CTD PMID:25926378 4,4'-sulfonyldiphenol increases expression ISO RGD:10836 6480464 bis4-hydroxyphenylsulfone results in increased expression of KDR mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO RGD:10836 6480464 Fenretinide results in increased expression of KDR mRNA CTD PMID:28973697 5-azacytidine increases expression EXP 6480464 Azacitidine results in increased expression of KDR mRNA CTD PMID:18037191 5-fluorouracil increases expression ISO RGD:10836 6480464 Fluorouracil results in increased expression of KDR mRNA CTD PMID:26272751 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of KDR mRNA CTD PMID:19483382 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions ISO RGD:10836 6480464 Omeprazole promotes the reaction [Oxygen results in decreased expression of KDR protein] CTD PMID:26272953 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of KDR mRNA CTD PMID:19483382 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of KDR mRNA CTD PMID:25825206 afimoxifene multiple interactions ISO RGD:731018 6480464 afimoxifene inhibits the reaction [Estradiol results in increased expression of KDR protein], afimoxifene inhibits the reaction [glyphosate results in increased expression of KDR protein] CTD PMID:29890199 aflatoxin B1 decreases expression ISO RGD:731018 6480464 Aflatoxin B1 results in decreased expression of KDR mRNA CTD PMID:22100608 , PMID:28943387 aldehydo-D-glucose multiple interactions ISO RGD:10836 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of KDR protein CTD PMID:19228841 aldehydo-D-glucose decreases expression ISO RGD:731018 6480464 Glucose results in decreased expression of KDR mRNA CTD PMID:31655124 all-trans-retinoic acid affects expression ISO RGD:10836 6480464 Tretinoin affects the expression of KDR mRNA CTD PMID:25137620 all-trans-retinoic acid affects expression ISO RGD:731018 6480464 Tretinoin affects the expression of KDR mRNA CTD PMID:31600526 all-trans-retinoic acid increases expression ISO RGD:10836 6480464 Tretinoin results in increased expression of KDR mRNA CTD PMID:26272751 all-trans-retinoic acid multiple interactions ISO RGD:731018 6480464 [Tretinoin co-treated with Phenylbutyrates co-treated with 1-hydroxy-2-oxo-3, 3-bis2-aminoethyl-1-triazene] results in increased expression of KDR protein CTD PMID:23284745 all-trans-retinoic acid decreases expression ISO RGD:731018 6480464 Tretinoin results in decreased expression of KDR mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression ISO RGD:731018 6480464 Tretinoin results in increased expression of KDR mRNA CTD PMID:17170094 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of KDR mRNA CTD PMID:19483382 andrographolide decreases expression ISO RGD:731018 6480464 andrographolide results in decreased expression of KDR mRNA CTD PMID:28651835 andrographolide multiple interactions ISO RGD:731018 6480464 [andrographolide co-treated with KDR protein] inhibits the reaction [VEGFA protein binds to KDR protein], andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of KDR protein] CTD PMID:24814888 arsenite(3-) increases methylation ISO RGD:731018 6480464 arsenite results in increased methylation of KDR promoter CTD PMID:23974009 arsenous acid decreases expression ISO RGD:731018 6480464 Arsenic Trioxide results in decreased expression of KDR more ... CTD PMID:18161919 more ... aspartame increases secretion ISO RGD:731018 6480464 Aspartame results in increased secretion of KDR protein CTD PMID:20837131 belinostat multiple interactions ISO RGD:731018 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of KDR mRNA CTD PMID:27188386 belinostat increases expression ISO RGD:731018 6480464 belinostat results in increased expression of KDR mRNA CTD PMID:26272509 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of KDR mRNA CTD PMID:19483382 benzo[a]pyrene decreases expression ISO RGD:731018 6480464 Benzoapyrene results in decreased expression of KDR mRNA CTD PMID:20106945 benzo[a]pyrene increases methylation ISO RGD:731018 6480464 Benzoapyrene results in increased methylation of KDR exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:731018 6480464 Benzoapyrene affects the methylation of KDR promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:10836 6480464 Benzoapyrene results in increased expression of KDR mRNA CTD PMID:21964900 more ... benzylpenicillin increases expression ISO RGD:10836 6480464 Penicillin G results in increased expression of KDR mRNA CTD PMID:25137620 benzylpenicillin decreases expression ISO RGD:10836 6480464 Penicillin G results in decreased expression of KDR mRNA CTD PMID:26272751 bis(2-chloroethyl) sulfide decreases expression ISO RGD:731018 6480464 Mustard Gas results in decreased expression of KDR mRNA CTD PMID:16173061 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:731018 6480464 IL10 protein affects the reaction [Mustard Gas affects the expression of KDR mRNA] CTD PMID:16173061 bisphenol A increases expression ISO RGD:731018 6480464 bisphenol A results in increased expression of KDR mRNA, bisphenol A results in increased expression of KDR protein CTD PMID:22045264 , PMID:25982407 bisphenol A decreases expression ISO RGD:731018 6480464 bisphenol A analog results in decreased expression of KDR mRNA CTD PMID:32387340 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of KDR mRNA CTD PMID:30816183 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Fructose] results in increased expression of KDR mRNA CTD PMID:27622962 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of KDR protein CTD PMID:22649256 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of KDR mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:10836 6480464 bisphenol A results in increased expression of KDR mRNA CTD PMID:26063408 , PMID:30951980 bisphenol A increases secretion ISO RGD:731018 6480464 bisphenol A results in increased secretion of KDR protein CTD PMID:25982407 Bisphenol A diglycidyl ether multiple interactions ISO RGD:731018 6480464 2, 2-bis4-glycidyloxyphenylpropane inhibits the reaction [1-methylimino-N-oxy-6-2-morpholinoethoxy-3-phenyl-1H-indene-2-carboxylic acid ethyl ester inhibits the reaction [VEGFA protein results in increased phosphorylation of KDR protein]] CTD PMID:21769449 bisphenol F increases expression ISO RGD:10836 6480464 bisphenol F results in increased expression of KDR mRNA CTD PMID:30951980 bortezomib multiple interactions ISO RGD:731018 6480464 [Bortezomib co-treated with sorafenib] results in decreased phosphorylation of KDR protein CTD PMID:16985072 cadmium atom affects activity ISO RGD:731018 6480464 Cadmium affects the activity of KDR protein CTD PMID:21425301 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of KDR mRNA CTD PMID:17293106 calcitriol decreases expression EXP 6480464 Calcitriol results in decreased expression of KDR protein CTD PMID:19092814 calcium atom multiple interactions ISO RGD:731018 6480464 [VEGFA protein results in increased activity of KDR protein] which results in increased abundance of Calcium, TRPC6 protein promotes the reaction [[VEGFA protein results in increased activity of KDR protein] which results in increased abundance of Calcium] CTD PMID:14551041 calcium atom multiple interactions ISO RGD:10836 6480464 Calcium promotes the reaction [Corticosterone results in decreased expression of KDR protein] CTD PMID:21647420 calcium(0) multiple interactions ISO RGD:731018 6480464 [VEGFA protein results in increased activity of KDR protein] which results in increased abundance of Calcium, TRPC6 protein promotes the reaction [[VEGFA protein results in increased activity of KDR protein] which results in increased abundance of Calcium] CTD PMID:14551041 calcium(0) multiple interactions ISO RGD:10836 6480464 Calcium promotes the reaction [Corticosterone results in decreased expression of KDR protein] CTD PMID:21647420 carbon nanotube decreases expression ISO RGD:10836 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube multiple interactions ISO RGD:10836 6480464 [Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of KDR mRNA CTD PMID:25926378 chlorpyrifos increases expression ISO RGD:10836 6480464 Chlorpyrifos results in increased expression of KDR mRNA CTD PMID:25137620 chlorpyrifos decreases expression ISO RGD:10836 6480464 Chlorpyrifos results in decreased expression of KDR mRNA CTD PMID:20350560 , PMID:23220036 choline multiple interactions ISO RGD:10836 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of KDR mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of KDR gene CTD PMID:20938992 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of KDR mRNA CTD PMID:19483382 clofibrate multiple interactions ISO RGD:10836 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of KDR mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of KDR mRNA] CTD PMID:17585979 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of KDR mRNA CTD PMID:17602206 cobalt dichloride decreases expression ISO RGD:731018 6480464 cobaltous chloride results in decreased expression of KDR mRNA CTD PMID:19320972 copper atom decreases expression EXP 6480464 Copper results in decreased expression of KDR protein CTD PMID:19542178 copper atom increases expression EXP 6480464 Copper results in increased expression of KDR mRNA CTD PMID:30556269 copper atom multiple interactions EXP 6480464 Copper inhibits the reaction [Phenylephrine results in increased expression of KDR protein] CTD PMID:24903162 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of KDR protein CTD PMID:19542178 copper(0) increases expression EXP 6480464 Copper results in increased expression of KDR mRNA CTD PMID:30556269 copper(0) multiple interactions EXP 6480464 Copper inhibits the reaction [Phenylephrine results in increased expression of KDR protein] CTD PMID:24903162 corticosterone multiple interactions ISO RGD:10836 6480464 1 more ... CTD PMID:21647420 corticosterone decreases expression ISO RGD:10836 6480464 Corticosterone results in decreased expression of KDR protein CTD PMID:21647420 coumarin increases expression ISO RGD:731018 6480464 coumarin analog results in increased expression of KDR mRNA CTD PMID:32578917 crocidolite asbestos increases secretion ISO RGD:731018 6480464 Asbestos, Crocidolite results in increased secretion of KDR protein CTD PMID:21762757 curcumin affects expression ISO RGD:731018 6480464 Curcumin affects the expression of KDR mRNA CTD PMID:17960570 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Carbon Tetrachloride results in increased expression of KDR mRNA], Curcumin inhibits the reaction [Carbon Tetrachloride results in increased expression of KDR protein] CTD PMID:23845850 curcumin multiple interactions ISO RGD:10836 6480464 Curcumin inhibits the reaction [Dietary Fats results in increased expression of KDR mRNA] CTD PMID:19297423 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of KDR mRNA, Cyclophosphamide results in decreased expression of KDR protein CTD PMID:19701751 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of KDR mRNA CTD PMID:18632792 cyclosporin A decreases expression ISO RGD:731018 6480464 Cyclosporine results in decreased expression of KDR mRNA CTD PMID:20106945 cyclosporin A multiple interactions EXP 6480464 Enalapril inhibits the reaction [Cyclosporine results in increased expression of KDR mRNA], Losartan inhibits the reaction [Cyclosporine results in increased expression of KDR mRNA] CTD PMID:12110003 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of KDR mRNA CTD PMID:12110003 cypermethrin increases expression ISO RGD:10836 6480464 cypermethrin results in increased expression of KDR mRNA CTD PMID:29020013 D-glucose multiple interactions ISO RGD:10836 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of KDR protein CTD PMID:19228841 D-glucose decreases expression ISO RGD:731018 6480464 Glucose results in decreased expression of KDR mRNA CTD PMID:31655124 Deguelin decreases expression ISO RGD:731018 6480464 deguelin metabolite results in decreased expression of KDR protein, deguelin results in decreased expression of KDR protein CTD PMID:19139008 demethoxycurcumin affects expression ISO RGD:731018 6480464 demethoxycurcumin affects the expression of KDR mRNA CTD PMID:17960570 diarsenic trioxide decreases expression ISO RGD:731018 6480464 Arsenic Trioxide results in decreased expression of KDR more ... CTD PMID:18161919 more ... diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of KDR mRNA CTD PMID:17005392 dioscin multiple interactions ISO RGD:731018 6480464 dioscin inhibits the reaction [VEGFA protein results in increased phosphorylation of KDR protein] CTD PMID:25111127 dioxygen multiple interactions ISO RGD:10836 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KDR mRNA more ... CTD PMID:19228841 more ... dioxygen increases expression ISO RGD:731018 6480464 Oxygen deficiency results in increased expression of KDR protein CTD PMID:31953908 dioxygen decreases expression ISO RGD:10836 6480464 Oxygen results in decreased expression of KDR mRNA, Oxygen results in decreased expression of KDR protein CTD PMID:22363622 , PMID:26272953 dioxygen increases phosphorylation ISO RGD:731018 6480464 Oxygen deficiency results in increased phosphorylation of KDR protein CTD PMID:8537383 dioxygen multiple interactions ISO RGD:731018 6480464 HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of KDR protein] more ... CTD PMID:23144690 , PMID:31953908 dorsomorphin multiple interactions ISO RGD:731018 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:731018 6480464 Doxorubicin results in decreased expression of KDR mRNA CTD PMID:29803840 embelin decreases expression ISO RGD:731018 6480464 embelin results in decreased expression of KDR protein CTD PMID:24694877 enalapril multiple interactions EXP 6480464 Enalapril inhibits the reaction [Cyclosporine results in increased expression of KDR mRNA] CTD PMID:12110003 Enterolactone multiple interactions ISO RGD:10836 6480464 2, 3-bis3'-hydroxybenzylbutyrolactone inhibits the reaction [Estradiol results in increased expression of KDR protein] CTD PMID:17289903 entinostat multiple interactions ISO RGD:731018 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of KDR mRNA CTD PMID:27188386 entinostat decreases expression ISO RGD:10836 6480464 entinostat results in decreased expression of KDR protein CTD PMID:21041383 entinostat increases expression ISO RGD:731018 6480464 entinostat results in increased expression of KDR mRNA CTD PMID:26272509 ethanol increases expression ISO RGD:10836 6480464 Ethanol results in increased expression of KDR mRNA CTD PMID:22198099 ethyl trans-caffeate affects expression ISO RGD:731018 6480464 ethyl caffeate affects the expression of KDR protein CTD PMID:24892518 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of KDR mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:10836 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 folic acid decreases expression ISO RGD:10836 6480464 Folic Acid results in decreased expression of KDR mRNA CTD PMID:25629700 fructose multiple interactions EXP 6480464 [bisphenol A co-treated with Fructose] results in increased expression of KDR mRNA CTD PMID:27622962 fumonisin B1 multiple interactions ISO RGD:10836 6480464 fumonisin B1 inhibits the reaction [1 more ... CTD PMID:15313899 furosemide increases expression EXP 6480464 Furosemide results in increased expression of KDR mRNA CTD PMID:16526316 gefitinib multiple interactions ISO RGD:10836 6480464 gefitinib inhibits the reaction [TGFA protein results in decreased expression of KDR mRNA] CTD PMID:18424623 genistein decreases expression ISO RGD:10836 6480464 Genistein results in decreased expression of KDR mRNA CTD PMID:21048042 , PMID:32186404 genistein decreases expression EXP 6480464 Genistein results in decreased expression of KDR protein CTD PMID:22649256 geraniol decreases expression ISO RGD:10836 6480464 geraniol results in decreased expression of KDR protein CTD PMID:26154255 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of KDR mRNA CTD PMID:24136188 glucose multiple interactions ISO RGD:10836 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of KDR protein CTD PMID:19228841 glucose decreases expression ISO RGD:731018 6480464 Glucose results in decreased expression of KDR mRNA CTD PMID:31655124 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of KDR mRNA CTD PMID:24915197 glyphosate multiple interactions ISO RGD:731018 6480464 afimoxifene inhibits the reaction [glyphosate results in increased expression of KDR protein] CTD PMID:29890199 glyphosate decreases expression ISO RGD:731018 6480464 glyphosate results in decreased expression of KDR mRNA CTD PMID:31295307 glyphosate increases expression ISO RGD:731018 6480464 glyphosate results in increased expression of KDR protein CTD PMID:29890199 hexachlorobenzene increases expression ISO RGD:731018 6480464 Hexachlorobenzene results in increased expression of KDR protein CTD PMID:26358519 indoles decreases expression EXP 6480464 Indoles results in decreased expression of KDR mRNA CTD PMID:20521778 indoles increases expression EXP 6480464 Indoles results in increased expression of KDR mRNA CTD PMID:20521778 isoprenaline decreases expression ISO RGD:10836 6480464 Isoproterenol results in decreased expression of KDR mRNA CTD PMID:20003209 L-ascorbic acid decreases expression ISO RGD:731018 6480464 Ascorbic Acid results in decreased expression of KDR mRNA CTD PMID:21919647 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of KDR mRNA CTD PMID:19483382 L-methionine multiple interactions ISO RGD:10836 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of KDR mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of KDR gene CTD PMID:20938992 lead diacetate decreases expression ISO RGD:10836 6480464 lead acetate results in decreased expression of KDR mRNA CTD PMID:20542052 lithium chloride increases expression ISO RGD:10836 6480464 Lithium Chloride results in increased expression of KDR mRNA CTD PMID:26272751 losartan multiple interactions EXP 6480464 Losartan inhibits the reaction [Cyclosporine results in increased expression of KDR mRNA] CTD PMID:12110003 medroxyprogesterone acetate decreases expression ISO RGD:731018 6480464 Medroxyprogesterone Acetate results in decreased expression of KDR mRNA CTD PMID:18497975 melittin decreases expression ISO RGD:731018 6480464 Melitten results in decreased expression of KDR protein CTD PMID:23110475 methoxychlor increases expression EXP 6480464 Methoxychlor results in increased expression of KDR protein CTD PMID:15503810 methyl caffeate decreases expression ISO RGD:731018 6480464 methyl caffeate analog results in decreased expression of KDR protein CTD PMID:25481497 methylisothiazolinone increases expression ISO RGD:731018 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of KDR mRNA CTD PMID:31629900 methylmercury chloride decreases expression ISO RGD:731018 6480464 methylmercuric chloride results in decreased expression of KDR mRNA CTD PMID:23179753 methylmercury chloride increases expression ISO RGD:731018 6480464 methylmercuric chloride results in increased expression of KDR mRNA CTD PMID:28001369 mifepristone multiple interactions ISO RGD:10836 6480464 Mifepristone inhibits the reaction [Corticosterone results in decreased expression of KDR protein] CTD PMID:21647420 monosodium L-glutamate increases expression EXP 6480464 Sodium Glutamate results in increased expression of KDR protein CTD PMID:28755050 N-acetyl-L-cysteine increases expression ISO RGD:731018 6480464 Acetylcysteine results in increased expression of KDR protein CTD PMID:17992120 N-acetylsphingosine multiple interactions ISO RGD:731018 6480464 sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of KDR mRNA] CTD PMID:15741222 N-acetylsphingosine multiple interactions ISO RGD:10836 6480464 N-acetylsphingosine results in decreased phosphorylation of and results in decreased activity of KDR protein CTD PMID:15313899 N-ethyl-N-nitrosourea increases expression ISO RGD:10836 6480464 Ethylnitrosourea results in increased expression of KDR protein CTD PMID:28549617 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of KDR mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of KDR mRNA CTD PMID:17602206 nickel atom decreases expression ISO RGD:10836 6480464 Nickel analog results in decreased expression of KDR mRNA CTD PMID:25144474 nicotine increases expression EXP 6480464 Nicotine results in increased expression of KDR mRNA CTD PMID:32512034 nicotinic acid increases expression ISO RGD:10836 6480464 Niacin results in increased expression of KDR mRNA CTD PMID:17557352 O-methyleugenol decreases expression ISO RGD:731018 6480464 methyleugenol results in decreased expression of KDR mRNA CTD PMID:32234424 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of KDR mRNA CTD PMID:19483382 omeprazole multiple interactions ISO RGD:10836 6480464 Omeprazole promotes the reaction [Oxygen results in decreased expression of KDR protein] CTD PMID:26272953 orantinib multiple interactions ISO RGD:731018 6480464 orantinib results in decreased phosphorylation of and results in decreased activity of KDR protein CTD PMID:16144927 orlistat decreases expression ISO RGD:731018 6480464 orlistat results in decreased expression of KDR protein CTD PMID:17012255 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of KDR mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] affects the expression of KDR mRNA CTD PMID:25729387 ozone decreases expression EXP 6480464 Ozone results in decreased expression of KDR mRNA CTD PMID:16330353 , PMID:31397875 p-menthan-3-ol increases expression ISO RGD:731018 6480464 Menthol results in increased expression of KDR mRNA CTD PMID:26760959 panobinostat multiple interactions ISO RGD:731018 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of KDR mRNA CTD PMID:27188386 paracetamol multiple interactions ISO RGD:10836 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of KDR mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of KDR mRNA] CTD PMID:17585979 paracetamol decreases expression ISO RGD:731018 6480464 Acetaminophen results in decreased expression of KDR mRNA CTD PMID:29067470 paracetamol increases expression ISO RGD:10836 6480464 Acetaminophen results in increased expression of KDR protein CTD PMID:16565415 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of KDR mRNA, Acetaminophen results in increased expression of KDR protein CTD PMID:17431590 PCB138 multiple interactions ISO RGD:10836 6480464 [2 more ... CTD PMID:25510870 PD123319 multiple interactions EXP 6480464 PD 123319 inhibits the reaction [AGT protein results in increased expression of KDR mRNA] CTD PMID:14638905 perfluorononanoic acid decreases expression ISO RGD:731018 6480464 perfluorononanoic acid results in decreased expression of KDR mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of KDR mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:731018 6480464 perfluorooctane sulfonic acid results in decreased expression of KDR mRNA CTD PMID:32588087 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of KDR mRNA CTD PMID:19162173 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of KDR mRNA CTD PMID:18158353 phenylephrine multiple interactions EXP 6480464 Copper inhibits the reaction [Phenylephrine results in increased expression of KDR protein] CTD PMID:24903162 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of KDR protein CTD PMID:24903162 phenytoin increases expression ISO RGD:10836 6480464 Phenytoin results in increased expression of KDR mRNA CTD PMID:26272751 phosgene affects expression ISO RGD:10836 6480464 Phosgene affects the expression of KDR mRNA CTD PMID:16300373 phosgene decreases expression EXP 6480464 Phosgene results in decreased expression of KDR mRNA, Phosgene results in decreased expression of KDR protein CTD PMID:18645720 pirinixic acid decreases expression ISO RGD:10836 6480464 pirinixic acid results in decreased expression of KDR mRNA CTD PMID:18445702 , PMID:20059764 pirinixic acid multiple interactions ISO RGD:10836 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of KDR mRNA] CTD PMID:20059764 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of KDR mRNA CTD PMID:19483382 platycodin D decreases phosphorylation ISO RGD:731018 6480464 platycodin D results in decreased phosphorylation of KDR protein CTD PMID:25250884 platycodin D affects binding ISO RGD:731018 6480464 platycodin D binds to KDR protein CTD PMID:25250884 ponatinib decreases activity ISO RGD:731018 6480464 ponatinib analog results in decreased activity of KDR protein, ponatinib results in decreased activity of KDR protein CTD PMID:19878872 , PMID:21561767 potassium dichromate increases expression ISO RGD:10836 6480464 Potassium Dichromate results in increased expression of KDR mRNA CTD PMID:23608068 progesterone increases expression EXP 6480464 Progesterone results in increased expression of KDR mRNA CTD PMID:20726854 progesterone increases expression ISO RGD:731018 6480464 Progesterone results in increased expression of KDR mRNA CTD PMID:18692832 quercetin multiple interactions ISO RGD:731018 6480464 Quercetin inhibits the reaction [VEGFA protein results in increased phosphorylation of KDR protein] CTD PMID:23094058 quercitrin increases expression ISO RGD:731018 6480464 quercitrin results in increased expression of KDR mRNA CTD PMID:25193878 quinazolines multiple interactions ISO RGD:731018 6480464 Quinazolines analog binds to and results in decreased activity of KDR protein CTD PMID:16302797 resveratrol multiple interactions ISO RGD:731018 6480464 [SU 1498 results in decreased activity of KDR protein] inhibits the reaction [resveratrol results in increased secretion of MMP2 protein] more ... CTD PMID:22314268 resveratrol decreases expression ISO RGD:731018 6480464 resveratrol results in decreased expression of KDR mRNA, resveratrol results in decreased expression of KDR protein CTD PMID:17992120 more ... resveratrol increases expression ISO RGD:731018 6480464 resveratrol results in increased expression of KDR mRNA, resveratrol results in increased expression of KDR protein modified form CTD PMID:20696143 , PMID:22314268 riddelliine multiple interactions EXP 6480464 riddelliine results in increased phosphorylation of and results in increased activity of KDR protein CTD PMID:15384251 riddelliine increases expression EXP 6480464 riddelliine results in increased expression of KDR protein CTD PMID:12460743 rosuvastatin calcium multiple interactions ISO RGD:10836 6480464 Rosuvastatin Calcium inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of KDR protein] CTD PMID:27097221 rotenone increases expression EXP 6480464 Rotenone results in increased expression of KDR mRNA CTD PMID:28374803 saccharin increases expression ISO RGD:10836 6480464 Saccharin results in increased expression of KDR mRNA CTD PMID:26272751 sarpogrelate multiple interactions ISO RGD:10836 6480464 sarpogrelate inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of KDR protein] CTD PMID:27097221 SB 431542 multiple interactions ISO RGD:731018 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 SB 431542 decreases expression ISO RGD:731018 6480464 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide results in decreased expression of KDR mRNA CTD PMID:25670856 silicon dioxide decreases expression ISO RGD:10836 6480464 Silicon Dioxide results in decreased expression of KDR mRNA CTD PMID:23221170 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of KDR mRNA, Simvastatin results in increased expression of KDR protein CTD PMID:19109527 simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Streptozocin results in increased expression of KDR mRNA], Simvastatin inhibits the reaction [Streptozocin results in increased phosphorylation of and results in increased expression of KDR protein] CTD PMID:20821229 simvastatin increases expression ISO RGD:10836 6480464 Simvastatin results in increased expression of KDR mRNA CTD PMID:15572054 sodium arsenite affects localization ISO RGD:731018 6480464 sodium arsenite affects the localization of KDR protein CTD PMID:29044176 sodium arsenite multiple interactions ISO RGD:731018 6480464 DAB2 protein affects the reaction [sodium arsenite affects the localization of KDR protein] CTD PMID:29044176 sorafenib multiple interactions ISO RGD:731018 6480464 [Bortezomib co-treated with sorafenib] results in decreased phosphorylation of KDR protein CTD PMID:16985072 sorafenib decreases phosphorylation ISO RGD:731018 6480464 sorafenib results in decreased phosphorylation of KDR protein CTD PMID:19139124 sphingosine 1-phosphate multiple interactions ISO RGD:731018 6480464 sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of KDR mRNA], sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of KDR mRNA] CTD PMID:15741222 streptozocin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Streptozocin results in increased expression of KDR mRNA] more ... CTD PMID:20821229 streptozocin multiple interactions ISO RGD:10836 6480464 [Dietary Fats co-treated with Streptozocin] results in increased expression of KDR protein more ... CTD PMID:27097221 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of KDR mRNA, Streptozocin results in increased expression of KDR protein CTD PMID:15643138 , PMID:20821229 sunitinib decreases expression ISO RGD:731018 6480464 Sunitinib results in decreased expression of KDR mRNA CTD PMID:31533062 superoxide increases phosphorylation ISO RGD:731018 6480464 Superoxides results in increased phosphorylation of KDR protein CTD PMID:19571580 tanespimycin decreases expression EXP 6480464 tanespimycin results in decreased expression of KDR protein CTD PMID:22810956 tanespimycin affects expression ISO RGD:731018 6480464 tanespimycin affects the expression of KDR protein CTD PMID:22810956 testosterone decreases expression ISO RGD:10836 6480464 Testosterone results in decreased expression of KDR mRNA CTD PMID:19693291 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of KDR mRNA, Carbon Tetrachloride results in increased expression of KDR protein CTD PMID:23845850 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of KDR mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 Curcumin inhibits the reaction [Carbon Tetrachloride results in increased expression of KDR mRNA], Curcumin inhibits the reaction [Carbon Tetrachloride results in increased expression of KDR protein] CTD PMID:23845850 thalidomide multiple interactions ISO RGD:731018 6480464 sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of KDR mRNA] CTD PMID:15741222 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of KDR mRNA CTD PMID:19483382 titanium dioxide decreases expression ISO RGD:10836 6480464 titanium dioxide results in decreased expression of KDR mRNA CTD PMID:27760801 toluene increases expression EXP 6480464 Toluene results in increased expression of KDR mRNA CTD PMID:22967744 topotecan increases expression EXP 6480464 Topotecan results in increased expression of KDR mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] affects the expression of KDR mRNA CTD PMID:25729387 trichloroethene multiple interactions ISO RGD:10836 6480464 PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of KDR protein] CTD PMID:15363585 trichloroethene increases expression ISO RGD:10836 6480464 Trichloroethylene results in increased expression of KDR mRNA CTD PMID:15363585 triclosan increases expression ISO RGD:731018 6480464 Triclosan results in increased expression of KDR mRNA CTD PMID:30510588 troglitazone decreases expression ISO RGD:10836 6480464 troglitazone results in decreased expression of KDR mRNA CTD PMID:28973697 troglitazone increases expression ISO RGD:10836 6480464 troglitazone results in increased expression of KDR mRNA CTD PMID:17569031 troglitazone multiple interactions ISO RGD:10836 6480464 [Urethane co-treated with troglitazone] results in increased expression of KDR mRNA CTD PMID:18465119 tunicamycin decreases expression ISO RGD:10836 6480464 Tunicamycin results in decreased expression of KDR mRNA CTD PMID:24370435 undecane increases expression EXP 6480464 undecane results in increased expression of KDR protein CTD PMID:17337753 urea decreases activity ISO RGD:731018 6480464 Urea analog results in decreased activity of KDR protein CTD PMID:16000000 urethane multiple interactions ISO RGD:10836 6480464 [Urethane co-treated with troglitazone] results in increased expression of KDR mRNA CTD PMID:18465119 urethane increases expression ISO RGD:10836 6480464 Urethane results in increased expression of KDR mRNA CTD PMID:18465119 valproic acid increases expression ISO RGD:10836 6480464 Valproic Acid results in increased expression of KDR mRNA CTD PMID:25137620 valproic acid increases expression ISO RGD:731018 6480464 Valproic Acid results in increased expression of KDR mRNA CTD PMID:28001369 valproic acid decreases expression ISO RGD:10836 6480464 Valproic Acid results in decreased expression of KDR mRNA CTD PMID:26272751 valproic acid affects expression ISO RGD:731018 6480464 Valproic Acid affects the expression of KDR mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:731018 6480464 Valproic Acid results in decreased expression of KDR mRNA CTD PMID:23179753 valproic acid affects expression ISO RGD:10836 6480464 Valproic Acid affects the expression of KDR mRNA CTD PMID:17963808 valsartan multiple interactions ISO RGD:731018 6480464 Valsartan inhibits the reaction [AGT protein results in increased expression of KDR mRNA] CTD PMID:15005273 valsartan multiple interactions EXP 6480464 Valsartan inhibits the reaction [AGT protein results in increased expression of KDR mRNA] CTD PMID:14638905 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of KDR mRNA CTD PMID:19015723 vorinostat increases expression ISO RGD:731018 6480464 vorinostat results in increased expression of KDR mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:731018 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of KDR mRNA CTD PMID:27188386 WIN 55212-2 multiple interactions ISO RGD:10836 6480464 fumonisin B1 inhibits the reaction [Win 55212-2 results in decreased phosphorylation of and results in decreased activity of KDR protein], Win 55212-2 results in decreased phosphorylation of and results in decreased activity of KDR protein CTD PMID:15313899 zinc atom decreases expression EXP 6480464 Zinc results in decreased expression of KDR mRNA CTD PMID:17074742 zinc sulfate decreases expression EXP 6480464 Zinc Sulfate results in decreased expression of KDR mRNA CTD PMID:17074742 zinc(0) decreases expression EXP 6480464 Zinc results in decreased expression of KDR mRNA CTD PMID:17074742
